At Keros, our mission is to innovate therapies that have the potential to shift the treatment paradigm for a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins.
Company Details
- Employees
- 145
- Founded
- 2016
- Address
- 1050 Waltham St,
- Phone
- (617)513-8774
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- kerostx.com
- HQ
- Lexington, Massachusetts
Keros Therapeutics Questions
Keros Therapeutics's helpline number is (617)513-8774
Keros Therapeutics's website is kerostx.com
Keros Therapeutics's LinkedIn profile is https://www.linkedin.com/company/keros-therapeutics
Keros Therapeutics has
145 employees.
View email and phone details for 145
employees at Keros Therapeutics.
Keros Therapeutics's industry is
Biotechnology Research
Keros Therapeutics's top competitors are
Tessera Therapeutics,
Kymera Therapeutics,
Intellia Therapeutics, Inc.,
Viridian Therapeutics, Inc.,
Takeda,
Sarepta Therapeutics,
Alnylam Pharmaceuticals,
Vertex Pharmaceuticals,
Abbvie,
Beam Therapeutics.
Keros Therapeutics's categories are Biotechnology Research
Keros Therapeutics's founding year is 2016
